Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

10.5%

2 terminated out of 19 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed with results

Key Signals

2 with results75% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (2)
P 1 (4)
P 2 (10)
P 4 (1)

Trial Status

Completed6
Unknown3
Recruiting3
Withdrawn3
Terminated2
Active Not Recruiting1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT07136571Not ApplicableWithdrawnPrimary

Phase I Study of Safety and Feasibility of Transarterial Embolization of Incurable Hypervascular Pediatric Soft Tissue Sarcomas

NCT07444619Phase 1Not Yet RecruitingPrimary

A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas

NCT04425967Not ApplicableActive Not RecruitingPrimary

Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas

NCT06849986Phase 2RecruitingPrimary

IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)

NCT04506008Phase 2RecruitingPrimary

Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas

NCT06593899Phase 2RecruitingPrimary

The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities

NCT02636725Phase 2Completed

Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas

NCT02536183Phase 1Terminated

A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors

NCT05739084UnknownPrimary

Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS

NCT04223583Phase 4CompletedPrimary

Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule

NCT03946943Phase 2UnknownPrimary

Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma

NCT02575066Phase 2Terminated

Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients

NCT03149120Phase 2WithdrawnPrimary

Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas

NCT00881595Phase 2WithdrawnPrimary

Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas

NCT01830153Phase 2CompletedPrimary

RAD001 in Advanced Sarcoma

NCT00385203Phase 2Completed

The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).

NCT00276302Phase 1Completed

Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)

NCT00423254Phase 1Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

NCT00687778UnknownPrimary

11C-Acetate PET/CT Non-FDG-Avid Tumors

Showing all 19 trials

Research Network

Activity Timeline